Stocks We’re Long On This Week | Midas Letter RAW ft $NUR $CCHW $AWKN

Happy Thanksgiving to our US watchers! But, Thanksgiving dinner is likely to be more expensive this year thanks to inflation and supply chain issues. Inflation has contributed to a rise in prices on grocery store shelves shown by the Consumer Price Index rise of 6.2% last month; The highest increase in 30 years. So, although your traditional feast might cost 14% more than last year, the good news is Midas Letter will talk you through some of the stocks we are long this week.

We answer which weed stocks will be best when the US finally legalizes the plant, commodity analysis, Voxtur Analytics upcoming financials, and of course present 3 exclusive interviews:

NuRAN Wireless Inc (CNSX:NUR, OTCMKTS:NRRWF) CFO Jim Bailey

NuRAN Wireless is a leading supplier of mobile and broadband wireless infrastructure solutions. The company has disrupted the telecom business by making it profitable to service rural areas. NuRAN’s and NaaS business model will connect the world’s most remote areas and transform social and economic challenges in locations people never had access to the internet before.

Columbia Care Inc (CNSX:CCHW, OTCMKTS:CCHWF) Chief Growth Officer Jesse Channon

Columbia Care is one of the original and largest cannabis providers worldwide, with in 18 U.S. jurisdictions and the EU. The company has built the correct brand partnerships to drive sales equating, most recently, in its record Q3 2021 financials reporting quarterly revenue of $132.3 million (an increase of 144% YoY, 21% QoQ). CCHW latest partnership includes iconic heavyweight champion Mike Tyson’s Tyson 2.0 cannabis brand.

Awakn Life Sciences (NEO:AWKN, OTCMKTS:AWKNF) CEO Anthony Tennyson

Awakn Life Sciences is a biotechnology company developing psychedelic therapeutics, both drugs and associated therapies) to better treat addiction. Awakn has acquired the exclusive rights to the world’s only phase IIb clinical trial for Ketamine-Assisted Psychotherapy to treat Alcohol Use Disorder. The company also has a pipeline of MDMA and novel compounds treating addictions. Awakn combines psychedelics with psychotherapy to treat mental health conditions in its clinics in Europe and the UK.

Original article: Stocks We’re Long On This Week | Midas Letter RAW ft $NUR $CCHW $AWKN

©2021 Midas Letter. All Rights Reserved.

More of Stocks We’re Long On This Week | Midas Letter RAW ft $NUR $CCHW $AWKN